You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Programmed Cell Death-1 (PD1, PD-1)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sickle Cell Disease Trial in Los Angeles (ßAS3-FB vector transduced peripheral blood CD34+ cells)

Recruiting
  • Sickle Cell Disease
  • βAS3-FB vector transduced peripheral blood CD34+ cells
  • Los Angeles, California
    University of California, Los Angeles (UCLA)
Apr 9, 2022

DLBCL Trial in Chicago (Metformin, Rituximab, Cyclophosphamide)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Chicago, Illinois
    Rush University Medical Center
Aug 24, 2021

TMJ Pain Trial (Hydrocortisone 2.5%, Diclofenac 1% topical)

Not yet recruiting
  • TMJ Pain
  • Hydrocortisone 2.5%
  • Diclofenac 1% topical
  • (no location specified)
Apr 3, 2023

Trauma Follow-Up Prediction (Project 2: Aim 1)

Not yet recruiting
  • Trauma
  • +2 more
  • Standard mHealth screening (triage) tool
  • (no location specified)
Jun 17, 2022

Small Cell Ovarian Carcinoma Trial in France (Pembrolizumab 25 MG/ML [Keytruda])

Recruiting
  • Small Cell Ovarian Carcinoma
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Angers, France
  • +10 more
Jul 13, 2022

Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

Active, not recruiting
  • Oropharyngeal Cancer
  • Prince George, British Columbia, Canada
  • +13 more
Dec 12, 2022

Solid Tumor Trial in Houston (IPN60090, pembrolizumab, paclitaxel)

Terminated
Has Results
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Jan 5, 2022

Immune Dysregulation in Patients With COVID-19

Recruiting
  • COVID-19
  • Immunosuppression
  • mid covid-19 patients
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jan 6, 2023

ALS Trial ([11C]CPPC PET ligand)

Not yet recruiting
  • ALS
  • [11C]CPPC PET ligand
  • (no location specified)
Jan 9, 2023

Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • BG1805
  • Guangzhou, Guangdong, China
  • +2 more
Nov 1, 2023

Gastric Cancer Trial in Beijing (Intraperitoneal chemo, Adjuvant systemic chemo)

Recruiting
  • Gastric Cancer
  • Intraperitoneal chemotherapy
  • Adjuvant systemic chemotherapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 10, 2022

Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)

Not yet recruiting
  • Renal Transplant Rejection
  • Renal Transplant Infection
  • (no location specified)
Nov 1, 2022

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +33 more
Sep 25, 2019

Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
Apr 12, 2022

Locally Advanced Cervical Cancer Trial in Shanghai (zimberelimab combined With concurrent radiotherapy and chemo)

Recruiting
  • Locally Advanced Cervical Cancer
  • zimberelimab combined With concurrent radiotherapy and chemotherapy
  • Shanghai, Shanghai, China
    Shanghai Zhongshan hospital
Jun 28, 2022

SARS-CoV-2 Specific CD8 T Cells in Humans

Recruiting
  • COVID-19
    • Baltimore, Maryland
      National Institute of Aging, Clinical Research Unit
    Jul 6, 2022

    Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • +2 more
    • Los Angeles, California
    • +12 more
    Jul 27, 2022

    Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)

    Recruiting
    • Olfactory Neuroblastoma
    • +2 more
    • Bintrafusp alfa / M7824
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Multiple Myeloma Trial in Chicago, Boston, Milwaukee (PHE885)

    Recruiting
    • Multiple Myeloma
    • PHE885
    • Chicago, Illinois
    • +4 more
    Jul 28, 2022

    KRAS p, G12c Mutated /Advanced Metastatic NSCLC Trial in Worldwide (AMG 510, Docetaxel)

    Active, not recruiting
    • KRAS p, G12c Mutated /Advanced Metastatic NSCLC
    • Anaheim, California
    • +273 more
    Nov 10, 2022

    HIV Trial in Canada, United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

    Completed
    • HIV Infections
    • Indinavir sulfate
    • +2 more
    • San Francisco, California
    • +43 more
    Oct 27, 2021

    Phantom Limb Pain, Pain, Chronic Trial in Medellin (Epidural catheter, Continuous sciatic nerve block)

    Not yet recruiting
    • Phantom Limb Pain
    • Pain, Chronic
    • Epidural catheter
    • Continuous sciatic nerve block
    • Medellin, Colombia
      Antioquia´s University
    Nov 2, 2022

    Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)

    Not yet recruiting
    • Healthy Adult Subjects
    • Tempe, Arizona
      Celerion, Inc.
    Jun 16, 2023

    Post-COVID19 Condition Trial in Badalona (Plasma Exchange Procedure, Sham Plasma Exchange Procedure)

    Recruiting
    • Post-COVID19 Condition
    • Plasma Exchange Procedure
    • Sham Plasma Exchange Procedure
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol Hospital
    Oct 3, 2022

    Prediction of Lupus Renal Flares Study

    Recruiting
    • Systemic Lupus Erythematosus
      • Berlin, Germany
        Department of Nephrology and Intensive Care, Charite University
      May 4, 2022